
Sign up to save your podcasts
Or


A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage at deep cold temperatures. The functionality of the primary packaging is strongly impacted at these temperatures and limited market know-how is available.
In this Pharmaversity™ session our experts will provide insight in how low temperature storage can influence the primary packaging and a science-based data package providing deep-dive on the container's functionality helping you to make a sound decision when choosing the container. Two solutions will be presented: one based on vials with optimized strength for applications down to -80°C and one based on prefillable syringes suitable for storage down to -100°C.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By SCHOTT PharmaA growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage at deep cold temperatures. The functionality of the primary packaging is strongly impacted at these temperatures and limited market know-how is available.
In this Pharmaversity™ session our experts will provide insight in how low temperature storage can influence the primary packaging and a science-based data package providing deep-dive on the container's functionality helping you to make a sound decision when choosing the container. Two solutions will be presented: one based on vials with optimized strength for applications down to -80°C and one based on prefillable syringes suitable for storage down to -100°C.
Learn more about your ad choices. Visit megaphone.fm/adchoices